Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of cisplatin and radiation with or without tirapazamine in cervical cancer was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Tirapazamine (tirapazamine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 3 | Status: TERMINATED | Results posted: 2017-07-02